PRESS RELEASE published on 06/02/2026 at 08:30, 2 months 13 days ago Nanobiotix rejoint l'indice Euronext Tech Leaders Nanobiotix rejoint l'indice Euronext Tech Leaders, initiative d'Euronext pour promouvoir les entreprises technologiques européennes à forte croissance. Nanobiotix utilise les nanoparticules en biotechnologie pour traiter le cancer et d'autres maladies Biotechnologie Cancer NANOBIOTIX Euronext Tech Leaders Nanoparticules
BRIEF published on 05/26/2026 at 23:04, 2 months 19 days ago NANOBIOTIX Completes Global Offering with $100 Million Proceeds Securities Biotechnology Investment Global Offering NANOBIOTIX
BRIEF published on 05/26/2026 at 23:04, 2 months 19 days ago NANOBIOTIX clôture son offre mondiale avec un produit de 100 millions de dollars Investissement Biotechnologie Titres Offre Globale NANOBIOTIX
PRESS RELEASE published on 05/26/2026 at 22:59, 2 months 19 days ago NANOBIOTIX annonce le règlement-livraison de son offre globale Nanobiotix annonce le règlement-livraison de son offre globale. Prix d'action de 33,60 €, soit 38,98 $ par ADS. Utilisation du produit net précisée. Jefferies, TD Cowen et Stifel ont agi comme coordinateurs globaux Offre Globale NANOBIOTIX Coordinateurs Globaux Produit Net Prix D'action
PRESS RELEASE published on 05/26/2026 at 22:59, 2 months 19 days ago NANOBIOTIX Announces Closing of Global Offering Nanobiotix closes global offering with total gross proceeds of $100 million. Proceeds to fund development and corporate purposes. Ordinary shares and ADSs issued Development ADSs Proceeds Global Offering NANOBIOTIX
BRIEF published on 05/22/2026 at 22:20, 2 months 23 days ago NANOBIOTIX lève 100 millions de dollars via une offre globale Biotechnologie Ads Levée De Fonds Cancer NANOBIOTIX
BRIEF published on 05/22/2026 at 22:20, 2 months 23 days ago NANOBIOTIX raises $100 million through a global offering Biotechnology Fundraising Ads Cancer NANOBIOTIX
PRESS RELEASE published on 05/22/2026 at 22:15, 2 months 23 days ago NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars Nanobiotix annonce l’exercice intégral de l’option de surallocation portant le produit de l'offre à 100 millions de dollars Biotechnologie Finance Actions Ordinaires Offre Globale NANOBIOTIX
PRESS RELEASE published on 05/22/2026 at 22:15, 2 months 23 days ago NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million Nanobiotix fully exercises underwriters' over-allotment option, raising gross proceeds of approximately $100 million from global offering. Proceeds allocated for development and general corporate purposes Development Underwriters Proceeds Global Offering NANOBIOTIX
BRIEF published on 05/21/2026 at 15:35, 2 months 24 days ago Nanobiotix reprend la cotation de ses actions ordinaires sur Euronext Paris Euronext Paris Biotechnologie Offre Globale NANOBIOTIX Reprise Des Échanges
Published on 08/15/2026 at 00:15, 9 hours 39 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 10 hours 9 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 10 hours 29 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 10 hours 54 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 1 hour 49 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 15 hours 39 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 17 hours 49 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 15 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 16 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 16 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 15 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 15 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026